Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Cholangiocellular Carcinoma

methylprednisolone hemisuccinate has been researched along with Cholangiocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamatsu, T; Rikimaru, T; Shimada, M; Shirabe, K; Sugimachi, K; Tanaka, S; Yamashita , Y1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and Cholangiocellular Carcinoma

ArticleYear
Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial.
    Archives of surgery (Chicago, Ill. : 1960), 2001, Volume: 136, Issue:3

    Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adult; Aged; Bile Duct Neoplasms; Bilirubin; C-Reactive Protein; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Hepatectomy; Humans; Interleukin-10; Interleukin-6; Liver Neoplasms; Male; Methylprednisolone Hemisuccinate; Middle Aged; Postoperative Complications; Premedication; Prospective Studies

2001